Ethan Marin

Medical Director
Regeneron Pharmaceuticals, Inc
Tarrytown, New York, United States

Presentation(s):

• PB0134 - A novel method for measuring ex vivo intrinsic pathway-triggered thrombin generation in the development of REGN9933, a monoclonal antibody targeting factor XI

  Sunday, June 23, 2024
  13:45 – 14:45 ICT